Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

Thu, 16th Jan 2020 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

BARCLAYS CUTS GLAXOSMITHKLINE TO 'UNDERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 1650 PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1860 (1800) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 8500 (8300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 8500 (8200) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS DIAGEO TO 'HOLD' (BUY) - PRICE TARGET 3600 PENCE

----------

JPMORGAN RAISES SEGRO PRICE TARGET TO 855 (775) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INFORMA PRICE TARGET TO 873 (869) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BRITISH LAND CO PRICE TARGET TO 630 (605) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PEARSON PRICE TARGET TO 860 (950) PENCE - 'OVERWEIGHT'

----------

UBS RAISES WPP PRICE TARGET TO 1175 (1125) PENCE - 'BUY'

----------

GOLDMAN REINITIATES VODAFONE WITH 'BUY' - PRICE TARGET 190 PENCE

----------

CREDIT SUISSE CUTS GLENCORE PRICE TARGET TO 300 (310) PENCE - 'OUTPERFORM'

----------

JPMORGAN RAISES BAE SYSTEMS PRICE TARGET TO 715 (700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES MEGGITT PRICE TARGET TO 730 (685) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

JPMORGAN CUTS UNITE GROUP TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1200 PENCE

----------

JPMORGAN CUTS BIG YELLOW TO 'UNDERWEIGHT' (NEUTRAL) - TARGET 1150 (1050) PENCE

----------

JPMORGAN RAISES WORKSPACE GROUP TARGET TO 1220 (1160) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ST. MODWEN PROPERTIES TARGET TO 530 (490) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES HAMMERSON PRICE TARGET TO 300 (290) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GREAT PORTLAND PRICE TARGET TO 880 (845) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GRAINGER PRICE TARGET TO 330 (310) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES DERWENT LONDON TARGET TO 3720 (3500) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ASSURA GROUP PRICE TARGET TO 81 (79) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ELECTROCOMPONENTS TO 'OVERWEIGHT' (NEUTRAL) - TARGET 774 (651) PENCE

----------

BARCLAYS CUTS SPIRENT TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 190 (159) PENCE

----------

JPMORGAN RAISES ULTRA ELECTRONICS PRICE TARGET TO 2400 (2200) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QINETIQ PRICE TARGET TO 360 (340) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES DIPLOMA PRICE TARGET TO 1760 (1730) PENCE - 'NEUTRAL'

----------

JPMORGAN INITIATES PPHE HOTELS WITH 'OVERWEIGHT' - TARGET 2500 PENCE

----------

UBS RAISES ASHMORE GROUP PRICE TARGET TO 527 (480) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE RAISES ASHMORE GROUP PT TO 480 (440) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS INTU PROPERTIES PRICE TARGET TO 25 (29) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HELICAL PRICE TARGET TO 475 (450) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES GAMMA COMMUNICATIONS PRICE TARGET TO 1350 (1250) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS IQE TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 55 (73) PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.